Helius Medical Technologies is trading at $1.72 (+5.5%) in pre-market, rebounding modestly after a weak week where shares fell during most sessions.
- The gain appears broadly aligned with a risk-on tone in U.S. futures, where major indices are up more than 0.8% ahead of the open.
- There are no fresh company-specific headlines, earnings, or FDA/clinical updates linked to the move so far.